GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Long-Term Debt

HLB Science (XKRX:343090) Long-Term Debt : ₩0.00 Mil (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science Long-Term Debt?

HLB Science's Long-Term Debt for the quarter that ended in . 20 was ₩0.00 Mil.

HLB Science's annual Long-Term Debt stayed the same from . 20 (₩0.00 Mil) to Dec. 2022 (₩0.00 Mil) but then increased from Dec. 2022 (₩0.00 Mil) to Dec. 2023 (₩1,000.86 Mil).


HLB Science Long-Term Debt Historical Data

The historical data trend for HLB Science's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Long-Term Debt Chart

HLB Science Annual Data
Trend Dec22 Dec23
Long-Term Debt
- 1,000.86

HLB Science Quarterly Data
Long-Term Debt

HLB Science  (XKRX:343090) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


HLB Science Long-Term Debt Related Terms

Thank you for viewing the detailed overview of HLB Science's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Science (XKRX:343090) Business Description

Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines